Who owns Elevation Oncology Inc?
- Ticker: ELEV
- CUSIP Number: 28623u101
Tip: Access positions for across all investors
Analyze quarterly positions in Elevation Oncology with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Elevation Oncology stock
Who bought or sold Elevation Oncology Inc this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Frazier Life Sciences Management | 6.0M | $3.6M | 103% | Sep 2024 |
|
| Tang Capital Management | 4.8M | $2.9M | 56% | Sep 2024 |
|
| Logos Global Management | 3.9M | $10M | 285% | Jun 2024 |
|
| Farallon Capital Management | 3.6M | $9.7M | -7% | Jun 2024 |
|
| BVF | 3.0M | $1.8M | 28% | Sep 2024 |
|
| BlackRock | 2.9M | $1.7M | 100% | Sep 2024 |
|
| Aisling Capital Management | 2.8M | $7.7M | 0% | Jun 2024 |
|
| BlackRock | 2.5M | $6.7M | 1349% | Jun 2024 |
|
| Balyasny Asset Management | 2.5M | $6.7M | -19% | Jun 2024 |
|
| Vanguard Group | 1.9M | $5.2M | 25% | Jun 2024 |
|
| Renaissance Technologies | 1.8M | $1.1M | 100% | Sep 2024 |
|
| Hudson Bay Capital Management | 1.4M | $815k | -43% | Sep 2024 |
|
| Palo Alto Investors | 1.3M | $779k | -28% | Sep 2024 |
|
| Morgan Stanley | 1.3M | $3.4M | 4437% | Jun 2024 |
|
| Geode Capital Management | 1.1M | $666k | 8% | Sep 2024 |
|
| OrbiMed Advisors | 941k | $565k | 0% | Sep 2024 |
|
| State Street Corporation | 897k | $2.4M | 711% | Jun 2024 |
|
| Ikarian Capital | 690k | $414k | 0% | Sep 2024 |
|
| Acadian Asset Management | 652k | $390k | 100% | Sep 2024 |
|
| Ghost Tree Capital | 600k | $1.6M | 140% | Jun 2024 |
|
| Schonfeld Strategic Advisors | 543k | $326k | 41% | Sep 2024 |
|
| Goldman Sachs Group | 504k | $1.4M | -9% | Jun 2024 |
|
| Braidwell | 474k | $284k | -81% | Sep 2024 |
|
| GSA Capital Partners | 434k | $260k | 100% | Sep 2024 |
|
| Northern Trust | 373k | $224k | 476% | Sep 2024 |
|
| Exome Asset Management | 369k | $997k | 0% | Jun 2024 |
|
| Sphera Funds Management | 330k | $891k | -23% | Jun 2024 |
|
| AQR Capital Management | 161k | $97k | 100% | Sep 2024 |
|
| Qube Research & Technologies | 132k | $356k | -8% | Jun 2024 |
|
| Bridgeway Capital Management | 128k | $346k | 20% | Jun 2024 |
|
| Charles Schwab Investment Management | 124k | $75k | -8% | Sep 2024 |
|
| Bank of New York Mellon | 124k | $74k | -19% | Sep 2024 |
|
| Millington Financial Advisors | 100k | $60k | 100% | Sep 2024 |
|
| Nuveen Asset Management | 81k | $219k | 100% | Jun 2024 |
|
| Barclays | 72k | $43k | 302% | Sep 2024 |
|
| Rhumbline Advisers | 65k | $39k | 0% | Sep 2024 |
|
| Jpmorgan Chase & Co | 61k | $37k | 176% | Sep 2024 |
|
| Two Sigma Investments | 60k | $161k | 100% | Jun 2024 |
|
| Alpine Partners VI | 50k | $135k | 100% | Jun 2024 |
|
| SG Americas Securities | 46k | $28k | 100% | Sep 2024 |
|
| Bank of America Corporation | 40k | $24k | -78% | Sep 2024 |
|
| Citigroup | 40k | $24k | 245% | Sep 2024 |
|
| Jane Street | 30k | $18k | -41% | Sep 2024 |
|
| Deutsche Bank Aktiengesellschaft | 29k | $17k | 0% | Sep 2024 |
|
| Citadel Advisors | 28k | $17k | -34% | Sep 2024 |
|
| Mirae Asset Global Etfs Holdings | 27k | $16k | 100% | Sep 2024 |
|
| Leucadia National Corporation | 25k | $68k | 37% | Jun 2024 |
|
| Invesco | 24k | $15k | -1% | Sep 2024 |
|
| Dynamic Technology Lab Private | 22k | $59k | 100% | Jun 2024 |
|
| Simplex Trading | 20k | $11k | 13165% | Sep 2024 |
|
| Wells Fargo & Company | 19k | $12k | 0% | Sep 2024 |
|
| Squarepoint Ops | 18k | $49k | -74% | Jun 2024 |
|
| Palumbo Wealth Management | 18k | $11k | 55% | Sep 2024 |
|
| T. Rowe Price Associates | 17k | $11k | 0% | Sep 2024 |
|
| Engineers Gate Manager | 14k | $8.2k | 100% | Sep 2024 |
|
| Tower Research Capital | 11k | $30k | 47726% | Jun 2024 |
|
| Mercer Global Advisors | 11k | $28k | 100% | Jun 2024 |
|
| OTR - Nominee Name for The State Teachers Retirement Board of Ohio | 9.7k | $5.8k | 0% | Sep 2024 |
|
| Royal Bank of Canada | 5.4k | $0 | 10% | Sep 2024 |
|
| New York State Common Retirement Fund | 5.2k | $3.0k | -87% | Sep 2024 |
|
| Summit Investment Advisors | 5.1k | $3.1k | 0% | Sep 2024 |
|
| California State Teachers Retirement System | 3.8k | $2.3k | 0% | Sep 2024 |
|
| Advisor Group Holdings | 2.0k | $1.2k | -33% | Sep 2024 |
|
| Amalgamated Bank | 1.8k | $999.970000 | 0% | Sep 2024 |
|
| CWM | 429.00 | $0 | 100% | Sep 2024 |
|
| NISA Investment Advisors | 147.00 | $87.994200 | 100% | Sep 2024 |
|
| Group One Trading | 100.00 | $60.000000 | 100% | Sep 2024 |
|
| Sterling Capital Management | 98.00 | $58.996000 | 100% | Sep 2024 |
|
| Capital Performance Advisors | 11.00 | $7.000400 | 100% | Sep 2024 |
|
Who sold out of Elevation Oncology?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| venBio Partners | Jun 2024 | 2.4M | $6.6M |
| Darwin Global Management | Jun 2024 | 1.9M | $4.8M |
| Point72 Asset Management | Jun 2024 | 1.7M | $4.5M |
| Affinity Asset Advisors | Jun 2024 | 1.5M | $4.0M |
| Artal Group | Jun 2024 | 1.0M | $2.7M |
| Octagon Capital Advisors | Jun 2024 | 747k | $2.0M |
| Dimensional Fund Advisors | Jun 2024 | 73k | $197k |
| Jump Financial | Jun 2024 | 50k | $134k |
| American Century Companies | Jun 2024 | 49k | $133k |
| XTX Topco | Jun 2024 | 38k | $103k |
| Marshall Wace | Jun 2024 | 38k | $102k |
| Ing Investment Management | Jun 2024 | 19k | $50k |
| Ameritas Advisory Services | Jun 2024 | 16k | $42k |
| MetLife Investment Advisors | Jun 2024 | 15k | $39k |
| Marathon Trading Investment Management | Jun 2024 | 14k | $37k |
| Macquarie Group | Mar 2024 | 1.3k | $7.007000 |